In light of the role of DC for the induction and polarization of adaptive anti-tumor responses [17] here we asked for potential off target effects of BRAFV600E inhibitors and for the immuno-modulatory role of coapplied MEK inhibitors at therapeutically relevant doses. This evidence concerns the gene MAP2K7 and neoplasm.